First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Market: NASD |
Currency: USD
Address: N/A
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
📈 First Trust Nasdaq Pharmaceuticals ETF Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.099000 |
- |
2025-03-27 |
- |
Dividend payout |
|
Total Amount for 2025: $0.099000 |
| 2024 |
- |
$0.130000 |
- |
2024-12-13 |
- |
Dividend payout |
| $0.122000 |
- |
2024-09-26 |
- |
Dividend payout |
| $0.128000 |
- |
2024-06-27 |
- |
Dividend payout |
| $0.068000 |
- |
2024-03-21 |
- |
Dividend payout |
|
Total Amount for 2024: $0.448000 |
| 2023 |
- |
$0.123000 |
- |
2023-12-22 |
- |
Dividend payout |
| $0.073000 |
- |
2023-09-22 |
- |
Dividend payout |
| $0.118000 |
- |
2023-06-27 |
- |
Dividend payout |
| $0.100000 |
- |
2023-03-24 |
- |
Dividend payout |
|
Total Amount for 2023: $0.414000 |
| 2022 |
- |
$0.125000 |
- |
2022-12-23 |
- |
Dividend payout |
| $0.091000 |
- |
2022-09-23 |
- |
Dividend payout |
| $0.038000 |
- |
2022-06-24 |
- |
Dividend payout |
| $0.049000 |
- |
2022-03-25 |
- |
Dividend payout |
|
Total Amount for 2022: $0.303000 |
| 2021 |
- |
$0.110000 |
- |
2021-12-23 |
- |
Dividend payout |
| $0.039000 |
- |
2021-09-23 |
- |
Dividend payout |
| $0.053000 |
- |
2021-06-24 |
- |
Dividend payout |
| $0.077000 |
- |
2021-03-25 |
- |
Dividend payout |
|
Total Amount for 2021: $0.279000 |
📅 Earnings & EPS History for First Trust Nasdaq Pharmaceuticals ETF
No earnings history available for this symbol.
📰 Related News & Research
No related articles found for "first trust".
